ADICET BIO INC (ACET) Stock Earnings & Estimates
USA - NASDAQ:ACET - US0070021086 - Common Stock
0.6623 USD
0 (-0.12%)
0.661 USD
0 (-0.2%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.9M | 9.73M -45.64% | 24.99M 156.83% | 637.5K -100.00% | 52.143M | 102.17M 95.94% | 213.49M 108.96% | 211.21M -1.07% | 362.02M 71.40% | |||||
| EBITDA YoY % growth | -37.96M 55.51% | -58.69M -54.61% | -69.97M -19.22% | -159.12M -81.36% | -156.06M 4.23% | -176.46M -45.20% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -39.19M 54.14% | -60.23M -53.69% | -72.55M -20.45% | -153.056M -83.32% | -133.443M 3.76% | -120.743M 5.67% | -126.239M -4.55% | -134.464M -6.52% | -89.593M 33.37% | -43.19M 51.79% | 38.104M 188.22% | -2.649M -106.95% | 134.78M 5,188.56% | |
| Operating Margin | -218.94% | -619.01% | -290.32% | -24,008.71% | N/A | N/A | N/A | N/A | -171.82% | -42.27% | 17.85% | -1.25% | 37.23% | |
| EPS YoY % growth | -5.68 65.62% | -2.07 63.56% | -1.71 17.39% | -3.39 -94.15% | -1.41 59.64% | -1.13 15.59% | -0.87 22.69% | -0.89 -2.18% | -0.43 52.34% | 0.06 113.58% | 0.90 1,457.85% | 0.75 -16.79% | 2.28 204.08% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 41.62% | -0.19 37.59% | -0.29 14.60% | -0.28 3.74% | -0.27 -44.15% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.207M 15.46% | -30.576M -1.92% | -31.626M 1.17% | -32.065M -10.32% | -32.453M -23.83% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.29 14.71% | -0.30 | 0.01 | 1.86% |
| Q2 2025 Q2Q % growth | -0.34 -3.03% | -0.31 | -0.03 | -9.54% |
| Q1 2025 Q2Q % growth | -0.31 11.43% | -0.34 | 0.03 | 8.37% |
| Q4 2024 Q2Q % growth | -0.32 53.62% | -0.37 | 0.05 | 13.38% |
| Q3 2024 Q2Q % growth | -0.34 70.69% | -0.35 | 0.01 | 2.10% |
| Q2 2024 Q2Q % growth | -0.33 56.00% | -0.37 | 0.04 | 11.06% |
| Q1 2024 Q2Q % growth | -0.35 51.39% | -0.40 | 0.05 | 11.52% |
| Q4 2023 Q2Q % growth | -0.69 4.17% | -0.71 | 0.02 | 2.60% |
| Q3 2023 Q2Q % growth | -1.16 -118.87% | -0.75 | -0.41 | -54.25% |
| Q2 2023 Q2Q % growth | -0.75 -33.93% | -0.70 | -0.05 | -7.88% |
| Q1 2023 Q2Q % growth | -0.72 -820.00% | -0.70 | -0.02 | -2.71% |
| Q4 2022 Q2Q % growth | -0.72 -53.19% | -0.28 | -0.44 | -153.00% |
| Q3 2022 Q2Q % growth | -0.53 -20.45% | -0.54 | 0.01 | 1.40% |
| Q2 2022 Q2Q % growth | -0.56 -64.71% | -0.46 | -0.10 | -20.66% |
| Q1 2022 Q2Q % growth | 0.10 112.20% | -0.19 | 0.29 | 153.87% |
| Q4 2021 Q2Q % growth | -0.47 -2.17% | -0.43 | -0.04 | -9.39% |
| Q3 2021 Q2Q % growth | -0.44 84.51% | -0.45 | 0.01 | 1.96% |
| Q2 2021 Q2Q % growth | -0.34 67.62% | -0.54 | 0.20 | 37.11% |
| Q1 2021 Q2Q % growth | -0.82 38.35% | -0.50 | -0.32 | -64.63% |
| Q4 2020 Q2Q % growth | -0.46 91.68% | -0.90 | 0.44 | 48.75% |
| Q3 2020 Q2Q % growth | -2.84 40.34% | -0.83 | -2.01 | -241.63% |
| Q2 2020 Q2Q % growth | -1.05 70.59% | -1.78 | 0.73 | 40.94% |
| Q1 2020 Q2Q % growth | -1.33 50.00% | -2.40 | 1.07 | 44.64% |
| Q4 2019 Q2Q % growth | -5.53 | -4.48 | -1.05 | -23.46% |
| Q3 2019 Q2Q % growth | -4.76 | -3.84 | -0.92 | -23.97% |
| Q2 2019 Q2Q % growth | -3.57 | -2.80 | -0.77 | -27.55% |
| Q1 2019 Q2Q % growth | -2.66 | -2.57 | -0.09 | -3.49% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 637.5K | -637.5K | -100.00% | |
| Q4 2023 Q2Q % growth | 637.5K | -637.5K | -100.00% | |
| Q3 2023 Q2Q % growth | 1.133M | -1.133M | -100.00% | |
| Q2 2023 Q2Q % growth | 12.92M | -12.92M | -100.00% | |
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | 11.787M | -11.787M | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | 339.997K | -339.997K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | 994.5K | -994.5K | -100.00% |
| Q1 2022 Q2Q % growth | 24.99M 727.89% | 13.964M | 11.026M | 78.96% |
| Q4 2021 Q2Q % growth | 5.47M 1.11% | 4.246M | 1.224M | 28.83% |
| Q3 2021 Q2Q % growth | 3.43M 13.20% | 2.739M | 691K | 25.23% |
| Q2 2021 Q2Q % growth | 4.81M -49.21% | 1.87M | 2.94M | 157.22% |
| Q1 2021 Q2Q % growth | -3.98M | 680.003K | -4.66M | -685.29% |
| Q3 2020 Q2Q % growth | 3.03M 142.98% | 3.03M | % | |
| Q2 2020 Q2Q % growth | 9.47M 56.01% | 9.47M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 2.03% | 7.47% | 4.86% |
| Revenue | N/A | N/A | N/A | N/A |